Nested RT-PCR Total RNA in mononuclear cells was extracted by Trizol reagent (Invitrogen, Carlsbad, CA, USA) and RNA concentration was measured by spectrophotometer (BioPhotometer, Eppendorf, Hamburg, German). Approximately 1 μg of total RNA was used for cDNA synthesis using a PrimeScript™ 1st Strand cDNA Synthesis Kit (TaKaRa, Shiga, Japan). PCR reaction was performed in a 25 μl volume comprised of 5 μl of DNA template, 10 × Buffer, 0.15 mM dNTPs, 0.1 mM of each primer

and 0.5U of Ex Taq Hot Start Version (Takara). Primer sequences and amplification conditions are listed in Table 1 and have been described elsewhere [11]. PCR products were identified on a 2% agarose gel containing ethidium bromide.

A resected ESCC tumor tissue and water blank were used as positive and negative control, respectively. Table 1 List of the nested PCR primers CB-839 in vivo Primers Sequences Selleck KPT 330 (5′-3′) Products PCR conditions STC-1 (outer) CTTCACTCAAGCCAGGAGAGGGAAAGAGGAAA 890 bp 94°C for 30s, 62°C for 30s, 72°C for 1 min, 40 cycles QNZ supplier TGGTGTGTCAACACCCCTAAAATGATA STC-1 (inner) GTGGCGGCTCAAAACTCAGCTGAA 645 bp 94°C for 30s, 60°C for 30s, 72°C for 1 min, 40 cycles TTATGCACTCTCATGGGATGTGCGTT β-actin CCCTGGACTTCGAGCAAGAGAT 531 bp 94°C for 30s, 55°C for 30s, 72°C for 1 min, 35 cycles GTTTTCTGCGCAAGTTAGG Statistical analysis Statistical tests were carried out using SPSS version 16.0 (SPSS Inc., Chicago, IL, USA). The differential expressions of STC-1 between tumor and adjacent normal specimens were calculated with Student’s t-test. Differences in frequency were assessed

by Chi-square test or Fisher’s exact test. Overall survival curves were calculated using the Kaplan-Meier method and compared by log-rank testing. Multivariate Cox proportional hazard models were used to define the potential prognostic significance enough of individual parameter. P < 0.05 was taken as statistically significant. Results STC-1 protein expression profiles in ESCC tissue We determined STC-1 protein expression in 85 pairs of ESCC and matched normal tissues by immunohistochemical staining. The representative immunohistochemical results are shown in Figure 1(A-D). In total, there were 71 cases (83.5%) showed a higher level of STC-1 protein expression in tumor tissues than in normal tissues, and the average immunostaining scores in tumor tissues were 3.08 ± 1.81 while in normal tissues was 1.05 ± 1.08 (Figure 1E, P < 0.001). Moreover, distribution of immunostaining scores per sample in tumor tissues and adjacent normal tissues was shown in Figure 1F, the rate of STC-1 protein high/moderate expression in ESCC and normal tissues was 65.9% (56/85) and 7.1% (6/85), respectively, which showed a significant difference (P < 0.001).